~/AI IN HEALTH/eli-lilly-ceo-pushes-back-against-ai-curing-cancer-within-a-decade

Eli Lilly CEO Pushes Back Against AI Curing Cancer Within a Decade

Eli Lilly CEO Dave Ricks publicly responded to Anthropic CEO Dario Amodei's prediction that AI could cure major diseases like cancer within a decade, stating that while the vision is appealing, it is unlikely to happen. This debate highlights the growing friction between tech industry optimism regarding artificial intelligence and the pragmatic realities faced by pharmaceutical leaders who must navigate strict medical regulations and biological complexities. Ricks noted that significant gaps in human biological knowledge and the rigid requirement for randomized human clinical trials will remain major bottlenecks that speed alone cannot overcome.

## BACKGROUND

Artificial intelligence is increasingly used in biopharma to accelerate early-stage drug discovery and identify candidate molecules. However, translating a laboratory discovery into an approved, safe, and effective medicine requires navigating complex, time-consuming clinical trials and regulatory approval processes.

## REFERENCES

## KEYWORDS

#AI in Healthcare#Biopharma#Artificial Intelligence#Medical Research

$ subscribe --daily

Eli Lilly CEO Pushes Back Against AI Curing Cancer Within a Decade | Daily News